XNAS
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-19 | Q1 2026 | — | -0.22 | — | $67,864 | — | -3.15% | +32.69% | — |
| 2026-04-01 | Q4 2025 | — | -0.13 | — | $94,360 | — | +0.03% | -6.39% | -11.72% |
| 2025-11-14 |
| Q3 2025 |
| — |
| -0.69 |
| — |
| $84,246 |
| — |
| — |
| — |
| — |
| 2025-03-20 | Q4 2024 | — | -1.01 | — | $105,247 | — | +2.53% | -45.29% | -42.76% |
| 2024-11-14 | Q3 2024 | — | -0.99 | — | $133,368 | — | -3.35% | +4.60% | +5.86% |
| 2024-08-14 | Q2 2024 | — | -1.35 | — | $163,163 | — | -2.74% | -12.31% | -17.93% |
| 2024-05-15 | Q1 2024 | — | -1.50 | — | $214,095 | — | +0.50% | +110.05% | +46.07% |
| 2024-04-01 | Q4 2023 | — | -1.80 | — | $244,374 | — | -2.33% | +32.33% | +23.26% |
Showing last 8 quarters.